company

DELTAKLINIKKEN AS

4056 TANANGER

Return on Equity
105,37 %
Current Ratio
1,42
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue5 606 000
Net Income726 000
Total Assets1 989 000
Total Equity689 000
Income (NOK)2022
Revenue5 606 000
Expenditure4 671 000
Operating Profit934 000
Financial Income0
Financial Costs1 000
Financial Balance−1 000
Earnings Before Tax934 000
Tax207 000
Net Income726 000
Balance (NOK)2022
Total Fixed Assets147 000
Total Current Assets1 842 000
Total Assets1 989 000
Total Retained Equity589 000
Total Equity689 000
Total Long-Term Debt0
Total Current Debt1 299 000
Total Equity and Debt1 989 000
Cash flow (NOK)2022
Sales Income5 606 000
Other Income0
Revenue5 606 000
Cost of Goods Sold6 000
Salary Costs1 138 000
Depreciation81 000
Impairment0
Expenditure4 671 000
Operating Profit934 000
Financial Income0
Financial Costs1 000
Financial Balance−1 000
Dividends500 000
Net Income726 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures147 000
Total Tangible Assets147 000
Total Fiancial Fixed Assets0
Total Fixed Assets147 000
Stock0
Total Investments0
Cash, Bank1 730 000
Total Current Assets1 842 000
Total Assets1 989 000
Total Equity689 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors390 000
Unpaid Taxes85 000
Dividends500 000
Other Current Debt117 000
Total Current Debt1 299 000
Total Equity and Debt1 989 000
Financial indicators2022
Return on Equity105,37 %
Debt-to-Equity Ratio0
Operating Profit Margin16,66 %
Current Ratio1,42
Quick Ratio1,42
Equity Ratio0,35
Gross Profit Margin99,89 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English